Effect of Cognitive-behavior Therapy on Fear Responses to Body Symptoms in Patients With Panic Disorder
NCT ID: NCT04568109
Last Updated: 2020-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2010-02-01
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mechanisms of Panic Disorders Treatment
NCT01323556
Cognitive Behavioral Therapy in Panic Disorder
NCT00772746
Cognitive Behavior Psychotherapy in Panic Disorder
NCT01025908
Neural Effects of Cognitive-behaviour Therapy in Panic Disorder
NCT03251235
Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia
NCT01928810
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposure-based cognitive-behavior therapy
Patients are treated in accordance with a manualized protocol (Gloster et al., 2011)
Cognitive-behavior therapy
The manualized protocol (Gloster et al., 2011) comprise of 12 weekly sessions of CBT focusing on therapist-guided interoceptive and in-situ exposure exercises.
Wait-List control condition
Patients are assessed prior to and after a 12-week waiting period. Patients are treated after this 12-week delay.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive-behavior therapy
The manualized protocol (Gloster et al., 2011) comprise of 12 weekly sessions of CBT focusing on therapist-guided interoceptive and in-situ exposure exercises.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 18 - 65 years
Exclusion Criteria
* any psychotic or bipolar disorder
* borderline personality disorder
* a medical condition that could explain patients' symptoms
* physical contradictions regarding application of exposure-based CBT (e.g., neurological disease)
* Patients has to be on a stable psychopharmacological medication schedule prior to study entry for at least 12 weeks
* Intake of benzodiazepines
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Federal Ministry of Education and Research
OTHER_GOV
Philipps University Marburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christane Pané-Farré
Prof. Dr. Christiane Pané-Farré
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alfons Hamm, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Psychology, University of Greifswald
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Greifswald
Greifswald, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PA_CBT_HV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.